Cited by 112Parasitic Infections and DiagnosticsHelminth infection and controlAmoebic Infections and Treatments

Activity of the Anthelmintic Benzimidazoles against Giardia lamblia In Vitro

Edlind, T. D., Hang, T. L., Chakraborty, P. R.·1990·Journal of Infectious Diseases

Abstract

In vitro growth of the protozoan parasite Giardia lamblia was highly sensitive to certain anthelmintic benzimidazoles. Albendazole and mebendazole were 30- to 50-fold more active than metronidazole and 4- to 40-fold more active than quinacrine. Thiabendazole, a noncarbamate benzimidazole, was less active. Since lack of intestinal absorption makes mebendazole an attractive new antigiardial agent, its in vitro activity was further characterized. At low concentrations (0.05 micrograms/ml) mebendazole had a static effect on G. lamblia growth; however, lethal activity was observed at a concentration fivefold lower (0.3 micrograms/ml) than necessary for the cidal agent metronidazole. Two observations are consistent with a microtubule target for mebendazole. First, attachment of cells to the culture tube, mediated by the ventral disk and flagella, was rapidly disrupted by mebendazole treatment. Second, the characteristic cell structure was grossly distorted by treatment. No mebendazole-resistant G. lamblia were detected in a population of 10(8) cells.

Integrity signals

Registry

Crossref · 10.1093/infdis/162.6.1408

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vitro growth of Giardia spp. is highly sensitive to albendazole and mebendazole, which have 30- to 50-fold higher activity than metronidazole, quinacrine, or tinidazole.

    “In vitro growth of Giardia spp. (G. lamblia, G. duodenalis, or G. intestinalis) was found to be highly sensitive to albendazole and mebendazole which had 30- to 50-fold higher activity than metronidazole, quinacrine, or tinidazole [266,267].”

Cited by

Sorted by citations

Authors
Edlind, T. D., Hang, T. L., & Chakraborty, P. R.
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Edlind, T. D.
Venue
Journal of Infectious Diseases
Published
1990-12-01
Volume
162
Issue
6
Pages
1408-1411
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2046832486
Cited by
112
References
0
Citations by year
2026: 1 · 2025: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
7.20
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
  • Health Sciences › Veterinary › Small Animals › Helminth infection and control
  • Health Sciences › Medicine › Infectious Diseases › Amoebic Infections and Treatments
Keywords
Giardia lamblia, benzimidazole, anthelmintic activity, mebendazole, albendazole, metronidazole, thiabendazole, quinacrine, cell attachment, flagella, drug resistance, giardiasis
MeSH terms
Animals, Dose-Response Relationship, Drug, Drug Resistance, Giardia, Mebendazole, Metronidazole, Quinacrine, Thiabendazole, Albendazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review